Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 8/20 | 0.61 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.61 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.61 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13873567 | 0.97 | CYP17A1 (0.65) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| SCHEMBL14257671 | 0.91 | CYP17A1 (0.54) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| SCHEMBL9512609 | 0.88 | CALM1 (0.67) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| SCHEMBL432308 | 0.88 | CALM1 (0.67) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| Ammonia Solution, Strong SCHEMBL6000295 | 0.86 | CALM1 (0.63) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| Bromide SCHEMBL21658864 | 0.86 | CALM1 (0.63) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| SCHEMBL29452943 | 0.86 | CALM1 (0.63) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| Hydrochloric Acid SCHEMBL28806112 | 0.86 | CALM1 (0.63) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| SCHEMBL23396882 | 0.84 | CYP11B1 (0.48) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 | |
| SCHEMBL171160 | 0.84 | CYP17A1 (0.54) | CYP17A1CYP11B1CYP11B2CYP3A4CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3933800-A | O-SUBSTITUTED OXIMES, MICROBIOCIDES | GRUPPO LEPETIT S.P.A. (IT) | 1976-01-20 | — | — | US | claimed |
| US-12016312-B2 | Animal models, screening methods, and treatment methods for intraocular diseases or disorders | Smilebiotek Zhuhai Limited (CN) | 2024-06-25 | — | — | US | disclosed |
| CN-118059541-A | Application of metal organic framework material as 1, 3-butadiene adsorbent and method for adsorbing and separating carbon-tetrahydrocarbon mixture | 浙江大学 | 2024-05-24 | — | — | CN | disclosed |
| US-11697884-B2 | Copper deposition in wafer level packaging of integrated circuits | MACDERMID ENTHONE INC. (US) | 2023-07-11 | — | — | US | disclosed |
| US-11697884-B2 | Copper deposition in wafer level packaging of integrated circuits | MACDERMID ENTHONE INC. (US) | 2023-07-11 | — | — | US | disclosed |
| EP-3419963-B1 | USE OF BISPYRIDINES TO IMPROVE LABELING OF NUCLEOPHILES | AGILENT TECHNOLOGIES INC (US) | 2022-08-10 | — | — | EP | disclosed |
| CN-108884030-B | Improved labeling of nucleophiles using bipyridines | 安捷伦科技有限公司 | 2022-06-28 | — | — | CN | disclosed |
| US-20220143201-A1 | COMPOSITION COMPRISING A POLYMERIC REAGENT | NEKTAR THERAPEUTICS (US) | 2022-05-12 | — | — | US | disclosed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | disclosed |
| CN-114420633-A | Copper deposition in wafer level packaging of integrated circuits | 麦克德米德乐思公司 | 2022-04-29 | — | — | CN | disclosed |
| EP-0676437-B1 | USE OF POLYCATIONIC POLYMER AS BACTERICIDAL/ALGICIDAL AGENT | SAGAMI CHEM RES (JP) | 1999-09-08 | — | — | EP | disclosed |
| US-5622953-A | DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG | BASF AKTIENGESELLSCHAFT (DE) | 1997-04-22 | — | — | US | disclosed |
| US-5616317-A | HETEROCYCLIC NITROGEN POLYMER | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0676437-A1 | POLYCATIONIC POLYMER AND POLYCATIONIC BACTERICIDAL/ALGICIDAL AGENT | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1995-10-11 | — | — | EP | disclosed |
| US-5405843-A | Anticancer drug potentiators | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0363212-B1 | Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components | MITSUI TOATSU CHEMICALS (JP) | 1995-01-04 | — | — | EP | disclosed |
| WO-1994022842-A1 | 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE | BASF AKTIENGESELLSCHAFT (DE) | 1994-10-13 | — | — | WO | disclosed |
| US-5204348-A | Quinoline derivatives | MITSUI TOATSU CHEMICALS INC. (JP) | 1993-04-20 | — | — | US | disclosed |
| US-5112817-A | Anticancer Drug Potentiators | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1992-05-12 | — | — | US | disclosed |
| EP-0363212-A2 | Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220143201-A1 | COMPOSITION COMPRISING A POLYMERIC REAGENT | CD44, FCGRT, C9 | CYP17A1 1151/4885CYP11B1 3379/4885CYP11B2 3345/4885 |
| US-12016312-B2 | Animal models, screening methods, and treatment methods for intraocular diseases or disorders | MB, MYOC, PDE6A | CYP17A1 4028/4885CYP11B1 2284/4885CYP11B2 1925/4885 |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | CYP17A1 1639/4885CYP11B1 891/4885CYP11B2 1431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.